WuXi Biologics (Cayman) I...

OTC: WXIBF · Real-Time Price · USD
4.00
0.10 (2.56%)
At close: Aug 15, 2025, 12:21 PM
3.90
-2.50%
After-hours: Aug 13, 2025, 08:00 PM EDT

WuXi Biologics (Cayman) Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
18.68B 17.12B 17.03B 16.55B 15.27B 13.09B 10.29B 8.08B
Cost of Revenue
11.02B 10.5B 10.21B 9.68B 8.54B 7.14B 5.46B 4.03B
Gross Profit
7.65B 6.62B 6.83B 6.87B 6.72B 5.95B 4.83B 4.05B
Operating Income
4.97B 3.47B 3.95B 4.17B 4.35B 4.01B 3.17B 2.79B
Interest Income
350.37M 64.67M 68.64M 25.73M 56.48M 51.2M 22.98M 43.52M
Pretax Income
4.83B 3.65B 4.17B 4.96B 5.36B 4.87B 3.99B 3.32B
Net Income
3.36B 2.63B 3.4B 4.15B 4.42B 4.08B 3.39B 2.79B
Selling & General & Admin
2.15B 2.36B 2.09B 1.96B 1.69B 1.25B 1.13B 952.31M
Research & Development
766.44M 795.2M 792.58M 759.88M 689.57M 663.58M 507.83M 299.93M
Other Expenses
-236.54M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
2.68B 3.15B 2.65B 1.93B 1.42B 1.12B 854.61M 765.14M
Interest Expense
157.59M n/a n/a 93.89M 651.72M 569.16M 242.56M 305.61M
Selling & Marketing Expenses
473.6M 411.68M 294.01M 201.2M 162.91M 131.39M 124.65M 106.31M
Cost & Expenses
13.7B 13.65B 12.86B 11.62B 9.96B 8.27B 6.32B 4.79B
Income Tax Expense
889.03M 640.13M 603.18M 690.07M 807.87M 618M 484.54M 474.11M
Shares Outstanding (Basic)
4.08B 4.3B 4.49B 4.36B 4.39B 4.37B 4.42B 4.39B
Shares Outstanding (Diluted)
4.23B 4.26B 4.35B 4.35B 4.37B 4.39B 4.44B 4.41B
EPS (Basic)
0.11 0.61 0.78 0.94 1.00 0.94 0.78 0.64
EPS (Diluted)
0.11 0.61 0.78 0.96 1.02 0.92 0.76 0.64
EBITDA
6.43B 4.6B 4.98B 5.02B 5.07B 4.6B 3.62B 3.16B
EBIT
4.99B 3.45B 3.93B 4.17B 4.35B 4.01B 3.17B 2.79B
Depreciation & Amortization
1.44B 1.15B 857.04M 659.82M 718.63M 585.58M 452.24M 367.9M